Search clinical trials for: VIX001

Total 90 results

Neobiosis, LLC

Not yet recruiting

Safety, Efficacy, and Dosing of VIX001 in Patients With Neurological Symptoms of Post Acute COVID-19 Syndrome (PACS).

Cognitive Impairment | Neurological Complication | Post-Acute COVID-19 Syndrome
AiViva BioPharma, Inc.

Completed

A Safety and Efficacy Study to Evaluate AIV001 in Wound Healing Following Surgical Incision

Scar | Incision | Abdominal | Wound (Morphologic Abnormality)

United States
Viravaxx AG
Gouya Insights; KKS MedUni Vienna

Recruiting

Study to Evaluate Induction of HBV Virus Neutralizing Antibodies Using VVX001

Hepatitis B

Austria
Shanghai Pudong Hospital
ImmuXell Biotech Ltd.

Recruiting

IX001 TCR-T In the Treatment of Advanced Pancreatic Cancer and Colorectal Cancer Induced by KRAS Mutations

Colorectal Cancer | Pancreatic Cancer

China
Basilea Pharmaceutica

Completed

Study to Assess Safety, Tolerability and Pharmacokinetics of APX001 Administered by Intravenous Infusion to Healthy Subjects

Fungal Infection

Netherlands
AiViva BioPharma, Inc.

Completed

Safety and Efficacy Evaluation of AIV001 in Nonmelanoma Skin Cancer of the Low Risk Basal Cell Carcinoma Subtype (NMSC)

Nodular Basal Cell Carcinoma | Superficial Basal Cell Carcinoma | Nonmelanoma Skin Cancers

United States
AiViva BioPharma, Inc.

Completed

Safety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following Keloidectomy

Scar | Keloid | Incision | Excision Margin

United States
Basilea Pharmaceutica

Completed

Safety, Pharmacokinetics, Bioavailability, Food Effect, Drug-Drug Interaction Study of APX001 Administered Orally

Fungal Infection

Netherlands
Liveome Inc.

Not yet recruiting

LIV001 in Patients with Mild-to-Moderate Active Ulcerative Colitis (UC)

Ulcerative Colitis (UC)

Poland
Mads Kjolby

Recruiting

Study in Asymptomatic GRN-FTD Patients to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VES001 (SORT-IN-2)

Dementia | Frontotemporal Dementia | Asymptomatic Condition

Netherlands, United Kingdom
Coegin Pharma AB
Bispebjerg Hospital; Studies&Me

Active, not recruiting

Phase I/IIa Trial to Evaluate AVX001 Gel in Doses of 1% or 3% Compared With Vehicle Over Four Weeks of Field-directed Treatment Period in Adult Subjects With AK (COAKS)

Actinic Keratoses

Denmark
Liveome Inc.

Completed

A Study of LIV001 in Healthy Subjects and Those with Mild-to-Moderate Active Ulcerative Colitis (UC)

Ulcerative Colitis

Australia
AiViva BioPharma, Inc.

Withdrawn

A Safety and Efficacy Study to Evaluate Rosacea

Papulopustular Rosacea

United States
Basilea Pharmaceutica

Completed

An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida Auris (APEX)

Candidemia | Candida Infection | Invasive Candidiases

South Africa
Vesper Biotechnologies ApS

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VES001 in Healthy Participants (SORT-IN-1)

Dementia, Frontotemporal

Netherlands
Visirna Therapeutics HK Limited
Arrowhead Pharmaceuticals

Not yet recruiting

Study of VSA001 Injection in Chinese Healthy Adult Volunteers

Healthy Adult Volunteers

China
Basilea Pharmaceutica

Completed

A Study to Assess the Mass Balance Recovery and Metabolite Profile & Identification of [14C]-APX001 in Healthy Males

Fungal Infection

United Kingdom
Basilea Pharmaceutica

Terminated

Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds (AEGIS)

Invasive Fungal Infections

Israel, Germany, United States, Belgium
Adrian Hernandez
Massachusetts General Hospital; Mayo Clinic; National Heart, Lung, and Blood... and other collaborators

Completed

Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF (INDIE-HFpEF)

Heart Failure

United States
Oppilan Pharma Ltd

Active, not recruiting

VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

Colitis, Ulcerative

United States, Bulgaria, Czechia, France, Georgia, Germany, Hungary, India, Italy, Korea, Republic of, Lithuania, Poland, Serbia, Slovakia
BioGend Therapeutics Co.Ltd

Active, not recruiting

OIF/β-TCP in Patients With Open Tibial Fractures in Need of Bone Grafting

Tibia Fracture

Taiwan
Kuhnil Pharmaceutical Co., Ltd.
Neurim Pharmaceuticals Ltd.

Completed

Efficacy and Safety of KI1001 in ≥ 55 Years Old Insomnia Patients

Sleep Initiation and Maintenance Disorders

Korea, Republic of
VivaVision Biotech, Inc

Completed

Study of VVN001 Ophthalmic Solution in Dry Eye Disease

Dry Eye

United States
ImmuneWorks

Completed

Trial Of IW001 in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

United States
Aires Pharmaceuticals, Inc.

Terminated

Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05

Pulmonary Arterial Hypertension

United States, Australia, Hungary
Vertex Pharmaceuticals Incorporated
CRISPR Therapeutics

Enrolling by invitation

A Long-term Follow-up Study in Participants Who Received CTX001

Hematologic Diseases | Genetic Diseases, Inborn | Sickle Cell Disease | Hemoglobinopathies | Sickle Cell Anemia | Thalassemia | Beta-Thalassemia

United States, United Kingdom, Belgium, Canada, Italy, Germany
VivaVision Biotech, Inc

Recruiting

Study of 5% VVN001 Ophthalmic Solution in Dry Eye Disease

Dry Eye

China
The Affiliated Hospital of Qingdao University
Beijing VDJBio Co., LTD.

Completed

A First-in-human Study of a Novel Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody

Healthy

China
Vaneltix Pharma, Inc.
Prevail Infoworks, Inc

Not yet recruiting

Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)

Interstitial Cystitis | Bladder Pain Syndrome
ViroXis Corporation
Progressive Clinical Research

Terminated

A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of External Genital Warts

Condylomata Acuminata

United States
Aires Pharmaceuticals, Inc.

Completed

Dose-Finding, Safety, Pharmacodynamic Effect Study of Sodium Nitrite Inhalation Solution in Normal, Healthy Volunteers (AIR001-CS02)

Pulmonary Arterial Hypertension

United States
Factor Therapeutics Ltd.
Parexel; ARANZ Medical; Almac Clinical Services LLC

Unknown

Study of VF001-DP in Patients With Chronic Venous Leg Ulcers

Pathologic Processes | Cardiovascular Diseases | Vascular Diseases | Skin Diseases | Ulcer | Leg Ulcer | Skin Ulcer | Varicose Ulcer

United States
Vaximm GmbH

Completed

VXM01 Phase I Pilot Study in Patients With Operable Recurrence of a Glioblastoma

Glioblastoma

Germany
Visirna Therapeutics HK Limited

Not yet recruiting

A Phase 3 Study of VSA001 in Chinese Adults With Familial Chylomicronemia Syndrome

Familial Chylomicronemia Syndrome
Kinarus AG

Suspended

The KIN-FAST Trial (KIN001 For Accelerated Symptoms Termination) in Non Hospitalized Patients Infected With SARS-CoV-2 (KIN-FAST)

COVID-19

Switzerland, Germany
University Medical Center Groningen
Dutch Cancer Society; ViciniVax B.V

Recruiting

Vvax001 Cancer Vaccine in Premalignant Cervical Lesions - Phase II (Vvax)

Cervical Intraepithelial Neoplasia | CIN3 | Cervical Intraepithelial Neoplasia Grade 3 | HPV 16 Infection

Netherlands
Vaximm GmbH

Completed

VXM01 Phase I Study in Patients With Metastatic Colorectal Cancer With Liver Metastasis

Colorectal Cancer

Germany
Basilea Pharmaceutica

Completed

An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With Candidemia

Candidemia

Germany, United States, Israel, Spain, Belgium
Vertex Pharmaceuticals Incorporated

Not yet recruiting

Evaluation of Efficacy and Safety of a Single Dose of Exa-cel in Participants With Severe Sickle Cell Disease, βS/βC Genotype

Sickle Cell Disease
Vertex Pharmaceuticals Incorporated
CRISPR Therapeutics

Recruiting

Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

Hematologic Diseases | Genetic Diseases, Inborn | Sickle Cell Disease | Hemoglobinopathies | Sickle Cell Anemia | Thalassemia | Beta-Thalassemia

United States, Italy, Germany, Saudi Arabia
Vertex Pharmaceuticals Incorporated
CRISPR Therapeutics

Recruiting

Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)

Hematologic Diseases | Genetic Diseases, Inborn | Hemoglobinopathies | Thalassemia | Beta-Thalassemia

Canada, United States, Italy, United Kingdom, Germany
U.S. Army Medical Research and Development Command
GlaxoSmithKline; United States Department of Defense; Walter Reed Army Institute... and other collaborators

Completed

Study of VMP001 and AS01B (Adjuvant Formulation) in Healthy Malaria-Naïve Adults

Malaria | Plasmodium Vivax

United States
University Medical Center Groningen
Dutch Cancer Society; ViciniVax B.V

Completed

Vvax001 Cancer Vaccine in (Pre) Malignant Cervical Lesions

Cervical Cancer | CIN 2/3

Netherlands
RVAC Medicines (US), Inc.

Terminated

Safety and Immunogenicity of RVM-V001 in Healthy Individuals Previously Vaccinated With BNT162b2 and mRNA-1273

COVID-19 | Infectious Disease

Australia
Schmidhofer, Mark, MD
Cystic Fibrosis Foundation; Mast Therapeutics, Inc.

Terminated

Inhaled Sodium Nitrite as an Antimicrobial for Cystic Fibrosis

Cystic Fibrosis

United States
Vertex Pharmaceuticals Incorporated
CRISPR Therapeutics

Recruiting

Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD)

Sickle Cell Disease | Hemoglobinopathies | Hematological Diseases | Hydroxyurea Failure | Hydroxyurea Intolerance

United States, Italy, United Kingdom, Germany
Vertex Pharmaceuticals Incorporated
CRISPR Therapeutics

Active, not recruiting

A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease

Sickle Cell Disease | Hemoglobinopathies | Hematological Diseases

United States, Belgium, Canada, France, Germany, Italy, United Kingdom
Basilea Pharmaceutica

Completed

A Bioequivalence Study of APX001 High-load and Low-load Tablets

Invasive Fungal Infections

United States
Hadassah Medical Organization

Completed

Efficacy of Sialic Acid GNE Related Thrombocytopenia (SA-thrombo)

Thrombocytopenia
Chimerix
Food and Drug Administration (FDA)

Withdrawn

An Open-Label Study , Safety and Tolerability of Brincidofovir for Post Exposure Prophylaxis of Ebola (BCV EBOV)

Ebola Virus Disease

Search clinical trials for: VIX001

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations